CLINICAL_TRIALS
trial_result
· 2022-08-09
Clinical Trial Update: Sub-dissociative Dose Ketamine Dosing Study [Phase 4]
Summary
A Phase 4 clinical trial evaluating sub-dissociative dose ketamine for acute pain has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Loyola University | Conditions: Acute Pain | Phase 4 | Status: COMPLETED | Results posted: 2022-08-09